Product Information
METFORMIN HCL 850 MG TABLET is a generic product labeled by Westminster Pharmaceuticals LLC, priced at $0.0247 per EA under NDC 69367018105. Its NADAC has been published 440 times since Jan 24, 2018.
Strength
850 mg/1
Manufacturer
Westminster Pharmaceuticals LLCNDC
69367018105
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203769On Market Since
11/21/2017
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL 850 MG TABLET has been published 440 times since Jan 24, 2018, and over the history we have for it it has declined 17.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0247 per EA |
|---|---|
| All-time high | $0.0322 (Mar 14, 2018) |
| All-time low | $0.0196 (May 22, 2024) |
| 52-week high | $0.0248 |
| 52-week low | $0.0224 |
| Median price | $0.0278 |
| Average price | $0.0271 |
| Largest weekly change | +26.0% (Jun 19, 2024) |
| Weeks tracked | 440 |
| Tracking since | Jan 24, 2018 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METFORMIN HCL 850 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 850 MG TABLET, manufactured by Westminster Pharmaceuticals LLC, is $0.0247 per EA (NDC 69367018105), effective Jun 24, 2026.
How has the price of METFORMIN HCL 850 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL 850 MG TABLET has declined 17.1%. It has been tracked across 440 weekly CMS publications since Jan 24, 2018.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL 850 MG TABLET?
Since Jan 24, 2018, the NADAC for METFORMIN HCL 850 MG TABLET has ranged from a low of $0.0196 (May 22, 2024) to a high of $0.0322 (Mar 14, 2018), with a median of $0.0278 per EA.
Are there cheaper alternatives to METFORMIN HCL 850 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as METFORMIN HCL 850 MG TABLET, but none are currently priced below it.
Who manufactures METFORMIN HCL 850 MG TABLET?
METFORMIN HCL 850 MG TABLET (NDC 69367018105) is labeled by Westminster Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification